In a groundbreaking phase 2 clinical trial, researchers have demonstrated the efficacy of olaparib, a PARP inhibitor, in treating metastatic...
A groundbreaking study reveals that 40 percent of women with ovarian cancer are first diagnosed following an emergency hospital admission,...
A team of researchers at The University of Texas MD Anderson Cancer Center has developed an innovative microfluidic platform named...
A groundbreaking clinical trial has revealed a promising new treatment for acquired hypothalamic obesity, a severe metabolic disorder arising from...
A groundbreaking study has unveiled a novel proteomic landscape underlying SMARCA-deficient esophageal adenocarcinoma (EAC), shedding light on new mechanisms of...
Global cancer cases are nearing 21 million worldwide in 2024, with deaths approaching 9.8 million, according to a comprehensive report...
For young women, the years immediately following childbirth may harbor a stealthier form of breast cancer. A new study from...
For decades, the script of cancer immunology seemed straightforward. Tumors evade destruction by hijacking immune checkpoints—inhibitory receptors on T cells...
In a sweeping analysis of over 2.4 million cancer cases across the United States, researchers have uncovered a stark and...
A rogue population of immune cells, long overlooked in the complex landscape of the human gut, has been unmasked as...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine